Wakamoto Pharmaceutical Co.,Ltd. (TYO:4512)

Wakamoto Pharmaceutical Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Fiscal Year	Current	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008
Period Ending	Jan 20, 2026	Mar 31, 2012	Mar 31, 2011	Mar 31, 2010	Mar 31, 2009	Mar 31, 2008
Market Capitalization	11,064	8,595	8,877	11,246	13,395	13,622
Market Cap Growth	37.66%	-3.18%	-21.07%	-16.05%	-1.66%	-60.29%
Enterprise Value	-	8,754	8,826	11,222	10,898	9,982
Last Close Price	318.00	225.97	233.29	293.41	343.90	344.62
PE Ratio	-	-	-	231.79	38.12	33.48
PS Ratio	1.17	0.91	0.92	1.15	1.33	1.34
PB Ratio	0.91	0.71	0.73	0.89	1.05	1.06
P/TBV Ratio	0.95	0.74	0.74	0.90	1.06	1.07
P/FCF Ratio	55.88	43.41	-	-	-	54.74
P/OCF Ratio	18.78	14.59	25.66	22.98	16.25	15.23
EV/Sales Ratio	-	0.93	0.91	1.15	1.08	0.98
EV/EBITDA Ratio	-	17.23	19.70	16.10	14.40	8.89
EV/EBIT Ratio	-	-	-	-	53.55	16.36
EV/FCF Ratio	-	44.21	-	-	-	40.11
Debt / Equity Ratio	0.14	0.14	0.12	0.13	0.00	-
Debt / EBITDA Ratio	3.26	3.26	3.28	2.37	0.04	-
Debt / FCF Ratio	8.37	8.37	-	-	-	-
Asset Turnover	0.55	0.55	0.55	0.55	0.58	0.61
Inventory Turnover	1.92	1.92	2.31	2.37	2.31	2.34
Quick Ratio	2.81	2.81	2.42	2.79	2.02	3.37
Current Ratio	4.30	4.30	3.56	3.75	2.69	4.15
Return on Equity (ROE)	-1.83%	-1.83%	-3.42%	0.38%	2.74%	3.27%
Return on Assets (ROA)	-1.84%	-1.84%	-2.71%	-0.08%	0.73%	2.28%
Return on Invested Capital (ROIC)	-2.28%	-2.28%	-3.38%	-0.10%	0.99%	3.07%
Return on Capital Employed (ROCE)	-3.40%	-3.40%	-5.10%	-0.10%	1.40%	4.10%
Earnings Yield	-2.01%	-2.58%	-4.79%	0.43%	2.62%	2.99%
FCF Yield	1.79%	2.30%	-1.36%	-18.85%	-7.47%	1.83%
Dividend Yield	0.95%	-	-	1.70%	1.45%	1.45%
Payout Ratio	-	-	-	355.21%	49.17%	41.43%
Buyback Yield / Dilution	-0.59%	-0.59%	-0.53%	0.11%	-1.62%	-4.30%
Total Shareholder Return	0.36%	-0.59%	-0.53%	1.82%	-0.17%	-2.85%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.